Exports In 2022, Spain exported $7.57B in Vaccines, blood, antisera, toxins and cultures, making it the 9th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most exported product in Spain. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Spain are: Japan ($2.71B), Singapore ($673M), Ireland ($639M), United States ($575M), and Germany ($556M).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Spain between 2021 and 2022 were Japan ($2.42B), Singapore ($666M), and Germany ($203M).
Imports In 2022, Spain imported $8.13B in Vaccines, blood, antisera, toxins and cultures, becoming the 11th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 7th most imported product in Spain. Spain imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($2.62B), Germany ($1.37B), United States ($1.24B), Belgium ($1.2B), and Netherlands ($683M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Spain between 2021 and 2022 were Belgium ($180M), Netherlands ($66.4M), and Poland ($52M).